Using the TCGA database of cancers, the TSC2 loss-of-function expression signature, as well as levels of LGALS3, were associated with bladder cancers harboring TSC1/TSC2 inactivating mutations. This evidence concerns the gene TSC1 and urinary bladder carcinoma.